| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |